MBA Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
MBA Advisors's LLY Position: Q2 2026 in Review
MBA Advisors increased its Eli Lilly (LLY) stake by 2% in Q2 2026, buying an estimated $11.2K and bringing the position to 573 shares worth $687K. The position accounts for 0.23% of the portfolio, ranked #80.
MBA Advisors first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- MBA Advisors held 573 shares of Eli Lilly worth $687K as of Q2 2026.
- MBA Advisors bought 11 Eli Lilly shares in Q2 2026, an estimated $11.2K.
- Eli Lilly made up 0.23% of MBA Advisors's portfolio in Q2 2026, its #80 holding.
- MBA Advisors first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on MBA Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.